UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Expanding options of child-friendly, single-tablet regimens for young children with HIV

The lancet HIV, 2024-05, Vol.11 (5), p.e275-e276

2024

Volltextzugriff (PDF)

Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings

AIDS (London), 2020-02, Vol.34 (2), p.255-260

2020

Volltextzugriff (PDF)

Single Dose Abacavir Pharmacokinetics and Safety in Neonates Exposed to Human Immunodeficiency Virus (HIV)

Clinical infectious diseases, 2021-06, Vol.72 (11), p.2032-2034

2021

Volltextzugriff (PDF)

Urine Tenofovir Concentrations Correlate With Plasma and Relate to Tenofovir Disoproxil Fumarate Adherence: A Randomized, Directly Observed Pharmacokinetic Trial (TARGET Study)

Clinical infectious diseases, 2020-05, Vol.70 (10), p.2143-2151

2020

Volltextzugriff (PDF)

Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus

Clinical infectious diseases, 2019-06, Vol.69 (1), p.144-146

2019

Volltextzugriff (PDF)

Paediatric abacavir–lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial

The lancet HIV, 2024-02, Vol.11 (2), p.e86-e95

2024

Volltextzugriff (PDF)

Advancing the prevention and treatment of HIV in children: priorities for research and development

The lancet HIV, 2022-09, Vol.9 (9), p.e658-e666

2022

Volltextzugriff (PDF)

Youth‐friendly services and a mobile phone application to promote adherence to pre‐exposure prophylaxis among adolescent men who have sex with men and transgender women at‐risk for HIV in Thailand: a randomized control trial

Journal of the International AIDS Society, 2020-09, Vol.23 (S5), p.e25564-n/a

2020

Volltextzugriff (PDF)

Tenofovir-Diphosphate in Dried Blood Spots vs Tenofovir in Urine/Plasma for Oral Preexposure Prophylaxis Adherence Monitoring

Open forum infectious diseases, 2022-08, Vol.9 (8), p.ofac405-ofac405

2022

Volltextzugriff (PDF)

Does pregnancy affect the pharmacokinetics of efavirenz?

AIDS (London), 2014-06, Vol.28 (10), p.1542-1543

2014

Volltextzugriff (PDF)

Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy

Clinical infectious diseases, 2015-07, Vol.61 (1), p.95-101

2015

Volltextzugriff (PDF)

Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand

AIDS (London), 2015-11, Vol.29 (18), p.2497-2507

2015

Volltextzugriff (PDF)

Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults With Moderate Renal Function Impairment

Clinical infectious diseases, 2015-08, Vol.61 (4), p.633-639

2015

Volltextzugriff (PDF)

Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial

The lancet HIV, 2022-05, Vol.9 (5), p.e332-e340

2022

Volltextzugriff (PDF)

Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list

The lancet HIV, 2019-09, Vol.6 (9), p.e623-e631

2019

Volltextzugriff (PDF)

Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study

The lancet HIV, 2022-01, Vol.9 (1), p.e24-e31

2022

Volltextzugriff (PDF)

Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing

Open forum infectious diseases, 2021-07, Vol.8 (7), p.ofab200-ofab200

2021

Volltextzugriff (PDF)

What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies

The lancet HIV, 2022-09, Vol.9 (9), p.e649-e657

2022

Volltextzugriff (PDF)

Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy

AIDS (London), 2010-09, Vol.24 (14), p.2193-2200

2010

Volltextzugriff (PDF)

A Comparison of 3 Regimens to Prevent Nevirapine Resistance Mutations in HIV-Infected Pregnant Women Receiving a Single Intrapartum Dose of Nevirapine

Clinical infectious diseases, 2012-01, Vol.54 (2), p.285-293

2012

Volltextzugriff (PDF)

Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine

AIDS (London), 2005-09, Vol.19 (14), p.1495-1499

2005

Volltextzugriff (PDF)

Plasma Drug Concentrations and Virologic Evaluations after Stopping Treatment with Nonnucleoside Reverse-Transcriptase Inhibitors in HIV Type 1–Infected Children

Clinical infectious diseases, 2008-05, Vol.46 (10), p.1601-1608

2008

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

Nur zeigenMit Volltextzugriff

ThemaImmunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

Infectious Diseases
(30)
Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Humans
(25)
Hiv Infections - Drug Therapy
(22)
Female
(21)
Male
(14)
Adult
(13)
Microbiology
(12)
Anti-Hiv Agents - Therapeutic Use
(11)
Child
(11)
Hiv
(11)
Infant
(11)
Pregnancy
(10)
Adolescent
(9)
Viral Load
(9)
Young Adult
(8)
Anti-Hiv Agents - Administration & Dosage
(7)
Child, Preschool
(7)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

6 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Lancet Hiv
(12)
Clinical Infectious Diseases
(10)
Clinical Infectious Diseases/clinical Infectious Diseases
(7)
Aids
(5)
The lancet. Hiv
(5)
Open Forum Infectious Diseases
(2)
Journal Of The International Aids Society
(1)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Expanding options of child-friendly, single-tablet regimens for young children with HIV

Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings

Single Dose Abacavir Pharmacokinetics and Safety in Neonates Exposed to Human Immunodeficiency Virus (HIV)

Urine Tenofovir Concentrations Correlate With Plasma and Relate to Tenofovir Disoproxil Fumarate Adherence: A Randomized, Directly Observed Pharmacokinetic Trial (TARGET Study)

Efficacy and Safety of 1-Month Postpartum Zidovudine-Didanosine to Prevent HIV-Resistance Mutations after Intrapartum Single-Dose Nevirapine

Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus

Paediatric abacavir–lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial

Advancing the prevention and treatment of HIV in children: priorities for research and development

Youth‐friendly services and a mobile phone application to promote adherence to pre‐exposure prophylaxis among adolescent men who have sex with men and transgender women at‐risk for HIV in Thailand: a randomized control trial

Tenofovir-Diphosphate in Dried Blood Spots vs Tenofovir in Urine/Plasma for Oral Preexposure Prophylaxis Adherence Monitoring

Does pregnancy affect the pharmacokinetics of efavirenz?

Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy

Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand

Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults With Moderate Renal Function Impairment

Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial

Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list

Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study

Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study

Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing

What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies

Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy

A Comparison of 3 Regimens to Prevent Nevirapine Resistance Mutations in HIV-Infected Pregnant Women Receiving a Single Intrapartum Dose of Nevirapine

Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine

Plasma Drug Concentrations and Virologic Evaluations after Stopping Treatment with Nonnucleoside Reverse-Transcriptase Inhibitors in HIV Type 1–Infected Children

Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate–Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum

Aktive Filter

Suchergebnisse filtern